Related Experiment Video
Updated: Sep 28, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Oxidative stress and apoptosis in heart dysfunction
Dinender Kumar1, Huiquan Lou, Pawan K Singal
1Cardiovascular Research Group, Department of Medicine, University of Wisconsin, Madison, WI, USA.
Insights
Antioxidants show promise in treating heart disease by inhibiting apoptosis, a process causing myocyte cell loss. This discovery offers new therapeutic avenues for cardiovascular conditions.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Heart disease pathogenesis involves complex mechanisms, including myocyte cell loss via apoptosis.
- Apoptosis is implicated in myocardial infarction, ischemia-reperfusion injury, heart failure, and cardiomyopathy.
Purpose of the Study:
- To elucidate the role of apoptosis in cardiac dysfunction.
- To investigate the regulatory processes of apoptosis in the heart.
- To explore potential therapeutic targets for heart disease.
Main Methods:
- Review of documented apoptotic regulatory pathways in cardiac disease.
- Analysis of pro-apoptotic (Bax, caspases, cytochrome c) and anti-apoptotic (Bcl-2, Akt, IAPs) protein expression.
- Investigation of the role of mitogen-activated protein kinases (MAPKs) in apoptosis and survival.
- Evaluation of oxidative stress and antioxidant effects on apoptotic pathways.
Main Results:
- Upregulation of pro-apoptotic proteins and/or downregulation of anti-apoptotic proteins are observed in cardiac diseases.
- Mitogen-activated protein kinases (MAPKs) play a dual role in apoptosis and cell survival.
- Inhibition of apoptotic pathways (e.g., caspase inhibitors, Bcl-2, Akt overexpression) can block apoptosis.
- Oxidative stress promotes apoptosis, while antioxidants inhibit this process.
Conclusions:
- Antioxidants demonstrate potential in inhibiting apoptotic pathways.
- This finding suggests novel therapeutic strategies for treating various heart diseases.
Background:
Heart disease is a major cause of morbidity and mortality due to its complex pathogenesis. Myocyte cell loss through apoptosis has been reported in a variety of cardiovascular disease conditions including myocardial infarction (MI), ischemia-reperfusion injury, end-stage heart failure and adriamycin cardiomyopathy.
Potential Apoptotic Factors And Therapeutic Target:
The cell biology of the apoptotic regulatory processes and the precise role of apoptosis in the development of cardiac dysfunction need to be established. The upregulation of proapoptic proteins, like Bax (a member of the Bcl-2 family proteins), caspases and cytochrome c, with or without the downregulation of antiapoptic proteins, including Bcl-2 (another member of the Bcl family), Akt and inhibitory apoptotic proteins (IAPs), has been documented in different cardiac disease conditions. However, mitogen-activated protein kinases (MAPKs) have been shown to be involved in both apoptosis and cell survival. Apoptosis can be blocked by inhibiting apoptotic regulatory pathways with caspase inhibitors and overexpression of Bcl-2 and Akt. More recently, increased oxidative stress has been shown to promote apoptosis, and antioxidants have been shown to inhibit this process.
Conclusion:
The ability of antioxidants to inhibit these apoptotic pathways has raised the possibility of newer therapeutic treatment for various heart diseases.
Related Concept Videos
Pathophysiology of Heart Failure
Apoptosis
Cellular Injury I: Introduction
Cellular Injury V: Apoptosis and Autophagy
Heart Failure I: Introduction
Heart Failure II: Pathophysiology

